Indian Journal of Respiratory Care

IJRC Email      Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  13 (2024)
Volume  12 (2023)
Volume  11 (2022)
Volume  10 (2021)
Volume  9 (2020)
Volume  8 (2019)
Volume  7 (2018)
Volume  6 (2017)
Volume  5 (2016)
Volume  4 (2015)
Volume  3 (2014)
Volume  2 (2013)
Volume  1 (2012)
Related articles

VOLUME 10 , ISSUE 1 ( January-April, 2021 ) > List of Articles

REVIEW ARTICLE

Lung Transplantation for Idiopathic Pulmonary Fibrosis: A Narrative Review

Nazia Mehfooz, Farhana Siraj, Parvaiz A Koul

Keywords : Idiopathic pulmonary fibrosis, lung allocation score, lung transplantation, survival

Citation Information : Mehfooz N, Siraj F, Koul PA. Lung Transplantation for Idiopathic Pulmonary Fibrosis: A Narrative Review. Indian J Respir Care 2021; 10 (1):24-29.

DOI: 10.4103/ijrc.ijrc_18_20

License: CC BY-NC-SA 4.0

Published Online: 06-12-2022

Copyright Statement:  Copyright © 2021; Indian Journal of Respiratory Care.


Abstract

Idiopathic pulmonary fibrosis (IPF) is a debilitating and progressive lung disease without an identifiable cause. It is the most common form of interstitial pneumonias. The prognosis is worst in this disease with median survival of just 2–3 years after diagnosis without a lung transplant. Currently, there are no proven medical therapies to cure IPF. Pharmacological agents such as nintedanib and pirfenidone retard the progression of the disease to an extent but without any survival benefit. The only therapeutic option for IPF is lung transplantation with proven survival benefit. The major concern with lung transplantation is waiting time mortality. Lung allocation score was introduced in 2005 to reduce this mortality. Both single- and double-lung transplantations are used worldwide for IPF. Bilateral lung transplantation has been seen to have better survival rates in some studies, but there are no randomized trials which favor this recent trend. The posttransplant survival is lower than seen in other indications for lung transplantation. Posttransplant follow-up should be vigilant to detect complications as early as possible and treat them accordingly.

HTML PDF Share
  1. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824.
  2. Raghu G, Rochwerg B, Zhang Y, Garcia CA, Azuma A, Behr J, et al. An official ATS/ERS/JRS/ALAT clinical practice guideline: Treatment of idiopathic pulmonary fibrosis. An Update of the 2011 clinical practice guideline. Am J Respir Crit Care Med 2015;192:e3-19.
  3. Caminati A, Cassandro R, Torre O, Harari S. Severe idiopathic pulmonary fibrosis: What can be done? Eur Respir Rev 2017;26:170047.
  4. Thabut G, Mal H, Castier Y, Groussard O, Brugière O, Marrash-Chahla R, et al. Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis. J Thorac Cardiovasc Surg 2003;126:469-75.
  5. King TE Jr., Schwarz MI, Brown K, Tooze JA, Colby TV, Waldron JA Jr., et al. Idiopathic pulmonary fibrosis: Relationship between histopathologic features and mortality. Am J Respir Crit Care Med 2001;164:1025-32.
  6. Christie JD, Edwards LB, Aurora P, Dobbels F, Kirk R, Rahmel AO, et al. The registry of the international society for heart and lung transplantation: Twenty-sixth official adult lung and heart-lung transplantation report- 2009. J Heart Lung Transplant 2009;28:1031-49.
  7. Chambers DC, Yusen RD, Cherikh WS, Goldfarb SB, Kucheryavaya AY, Khusch K, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth adult lung and heart-lung transplantation report-2017; Focus theme: Allograft ischemic time. J Heart Lung Transplant 2017;36:1047-59.
  8. Hardy JD, Webb WR, Dalton ML Jr., Walker GR Jr. Lung homotransplantation in man. JAMA 1963;186:1065-74.
  9. Magovern GJ, Yates AJ. Human homotransplantation of left lung: Report of a case. Ann N Y Acad Sci 1964;120:710-28.
  10. Derom F, Barbier F, Ringoir S, Versieck J, Rolly G, Berzenyi G, et al. Ten-month survival after lung homotransplantation in man. J Thorac Cardiovasc Surg 1971;61:835-46.
  11. Toronto Lung Transplant Group. Unilateral lung transplantation for pulmonary fibrosis. N Engl J Med 1986;314:1140-5.
  12. Egan TM, Murray S, Bustami RT, Shearon TH, McCullough KP, Edward LB, et al. Development of the new lung allocation system in the United States. Am J Transplant 2006;6:1212-27.
  13. Kistler KD, Nalysnyk L, Rotella P, Esser D. Lung transplantation in idiopathic pulmonary fibrosis: A systematic review of the literature. BMC Pulm Med 2014;14:139.
  14. Yusen RD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Dobbels F, et al. The registry of the International Society for Heart and Lung Transplantation: Thirty-first adult lung and heart-lung transplant report–2014; focus theme: Retransplantation. J Heart Lung Transplant 2014;33:1009-24.
  15. Patterson GA, Cooper JD, Goldman B, Weisel RD, Pearson FG, Waters PF, et al. Technique of successful clinical double-lung transplantation. Ann Thorac Surg 1988;45:626-33.
  16. Hernandez RL, Perez MA, Lázaro Carrasco MT, Gil PU. Lung transplantation in idiopathic pulmonary fibrosis. Med Sci 2018;6:68.
  17. George TJ, Arnaoutakis GJ, Shah AS. Lung transplant in idiopathic pulmonary fibrosis. Arch Surg 2011;146:1204-9.
  18. Orens JB, Estenne M, Arcasoy S, Conte JV, Corris P, Egan JJ, et al. International guidelines for the selection of lung transplant candidates: 2006 update – A consensus report from the Pulmonary Scientific Council of the International Society for Heart and LungTransplant. JHLT 2006;25:745-55.
  19. Weill D, Benden C, Corris PA, Dark JH, Davis RD, Keshavjee S, et al. A consensus document for the selection of lung transplant candidates: 2014 – An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2015;34:1-5.
  20. Nathan SD. Lung transplant candidate selection and clinical outcomes: Strategies for improvement in prioritization. Curr Opin Organ Transplant 2005;10:216-20.
  21. LAS Calculator Guide. Available from: http://www.unos.org/SharedContentDocuments/lung_allocation_score_updated_01072009.pdf. [Last accessed on 2019 Nov 20].
  22. Sulica R, Teirstein A, Padilla ML. Lung transplantation in interstitial lung disease. Curr Opin Pulm Med 2001;7:314-22.
  23. Meyers BF, Lynch JP, Trulock EP, Guthrie T, Cooper JD, Patterson GA. Single versus bilateral lung transplantation for idiopathic pulmonary fibrosis: A ten year institutional experience. J Thorac Cardiovasc Surg 2000;120:99-107.
  24. O'Beirne S, Counihan IP, Keane MP. Interstitial lung disease and lung transplantation. Semin Respir Crit Care Med 2010;31:139-46.
  25. Weiss ES, Allen JG, Merlo CA, Conte JV, Shah AS. Lung allocation score predicts survival in lung transplantation patients with pulmonary fibrosis. Ann Thorac Surg 2009;88:1757-64.
  26. Fisher JH, Al-Hejaili F, Kandel S, Hirji A, Shapera S, Mura M. Multi-dimensional scores to predict mortality in patients with idiopathic pulmonary fibrosis undergoing lung transplantation assessment. Respir Med 2017;125:65-71.
  27. Salisbury ML, Xia M, Zhou Y, Murray S, Tayob N, Brown KK, et al. Idiopathic pulmonary fibrosis: gender-age-physiology index stage for predicting future lung function decline. Chest 2016;149:491-8.
  28. Kumar A, Kapnadak SG, Girgis RE, Raghu G. Lung transplantation in idiopathic pulmonary fibrosis. Expert Rev Respir Med 2018;12:375-85.
  29. Raghu G, Freudenberger TD, Yang S, Curtis JR, Spada CJ, Hayes CE, et al. High prevalence of abnormal acidgastro -oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J 2006;27:136-42.
  30. Savarino E, Carbone R, Marabotto E, Furnari M, Sconfienza L, Ghio M, et al. Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients. Eur Respir J 2013;42:1322-31.
  31. Vaquero BJ, Redel MJ, Santos LF. Comorbidities impacting on prognosis after lung transplant. Arch Bronconeumol 2014;50:25-33.
  32. Justin MO, Collard HR. Comorbid conditions in idiopathic pulmonary fibrosis: Recognition and management. Front Med 2017;4:123.
  33. Fang A, Studer S, Kawut SM, Ahya VN, Lee J, Wille K, et al. Elevated pulmonary artery pressure is a risk factor for primary graft dysfunction following lung transplantation for idiopathic pulmonary fibrosis. Chest 2011;139:782-7.
  34. Dai J, Cai H, Li H, Zhuang Y, Min H, Wen Y, et al. Association between telomere length and survival in patients with idiopathic pulmonary fibrosis. Respirology 2015;20:947-52.
  35. Cronkhite JT, Xing C, Raghu G, Chin KM, Torres F, Rosenblatt RL, et al. Telomere shortening in familial and sporadic pulmonary fibrosis. Am J Respir Crit Care Med 2008;178:729-37.
  36. Newton CA, Kozlitina J, Lines JR, Kaza V, Torres F, Garcia CK. Telomere length in patients with pulmonary fibrosis associated with chronic lung allograft dysfunction and post-lung transplantation survival. J Heart Lung Transplant 2017;36:845-53.
  37. Tsiouris A, Budev MM, Yun JJ. Extracorporeal membrane oxygenation as a bridge to lung transplantation in the United States: A multicenter survey. ASAIO J 2018;64:689-93.
  38. Gaunaurd IA, Gómez-Marín OW, Ramos CF, Sol CM, Cohen MI, Cahalin LP, et al. Physical activity and quality of life improvements of patients with idiopathic pulmonary fibrosis completing a pulmonary rehabilitation program. Respir Care 2014;59:1872-9.
  39. Delanote I, Wuyts WA, Yserbyt J, Verbeken EK, Verleden GM, Vos R. Safety and efficacy of bridging to lung transplantation with antifibrotic drugs in idiopathic pulmonary fibrosis: A case series. BMC Pulm Med 2016;16:156.
  40. Leuschner G, Stocker F, Veit T, Kneidinger N, Winter H, Schramm R, et al. Outcome of lung transplantation in idiopathic pulmonary fibrosis with previous anti-fibrotic therapy. J Heart Lung Transplant 2017. pii: S1053-2498 (17) 31886-7.
  41. Force SD, Kilgo P, Neujahr DC, Pelaez A, Pickens A, Fernandez FG, et al. Bilateral lung transplantation offers better long- term survival, compared with single-lung transplantation, for younger patients with idiopathic pulmonary fibrosis. Ann Thorac Surg 2011;91:244-9.
  42. Yusen RD, Edwards LB, Dipchand AI, Goldfarb SB, Kucheryavaya AY, Leevvey BJ, et al. The registry of the international nSociety for heart and lung transplantation: Thirty-third adult lung and heart-lung transplant report-2016; Focus Theme: Primary diagnostic indications for transplant. J Heart Lung Transplant 2016;35:1170-84.
  43. King TE Jr., Tooze JA, Schwarz MI, Brown KR, Cherniack RM. Predicting survival in idiopathic pulmonary fibrosis: Scoring system and survival model. Am J Respir Crit Care Med 2001;164:1171-81.
  44. Brown AW, Kaya H, Nathan SD. Lung transplantation in IIP: A review. Respirology 2016;21:1173-84.
  45. Christie JD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Dobbels F, et al. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report- 2012. J Heart Lung Transplant 2012;31:1073-86.
  46. de Perrot M, Chaparro C, McRae K, Waddell TK, Hadjiliadis D, Singer LG, et al. Twenty-year experience of lung transplantation at a single center: Influence of recipient diagnosis on long-term survival. J Thorac Cardiovasc Surg 2004;127:1493-501.
  47. Lee JC, Christie JD, Keshavjee S. Primary graft dysfunction: Definition, risk factors, short- and long-term outcomes. Semin Respir Crit Care Med 2010;31:161-71.
  48. Arcasoy SM, Fisher A, Hachem RR, Scavuzzo M, Ware LB; ISHLT Working Group on Primary Lung Graft Dysfunction. Report of the ISHLT working group on primary lung graft dysfunction part V: Predictors and outcomes. J Heart Lung Transplant 2005;24:1483-8.
  49. Krishnam MS, Suh RD, Tomasian A, Goldin JG, Lai C, Brown K, et al. Postoperative complications of lung transplantation: Radiologic findings along a time continuum. Radiographics 2007;27:957-74.
  50. Pakhale SS, Hadjiliadis D, Howell DN, Palmer SM, Gutierrez C, Waddell TK, et al. Upper lobe fibrosis: A novel manifestation of chronic allograft dysfunction in lung transplantation. J Heart Lung Transplant 2005;24:1260-8.
  51. Nathan SD, Barnett SD, Urban BA, Nowalk C, Moran BR, Burton N. Pulmonary embolism in idiopathic pulmonary fibrosis transplant recipients. Chest 2003;123:1758-63.
  52. Vb Vicente R, Morales P, Ramos F, Sole×A, Mayo M, Villalain C. Perioperative complications of lung transplantation in patients with emphysema and fibrosis: Experience from 1992-2002. Transplant Proc 2006;38:2560-2.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.